
Hims & Hers $1.2 Billion Global Leap: Can Eucalyptus Cure its GLP-1 Ills?
Hims & Hers Health (NYSE:HIMS) just made a bold move to take its personalized wellness platform global. The company announced it is acquiring Eucalyptus, a leading digital health player based in Australia, in a deal worth up to $1.15 billion. The move aims to accelerate global expansion by entering Australia and Japan while strengthening its ... Hims & Hers $1.2 Billion Global Leap: Can Eucalyptus Cure its GLP-1 Ills?The post Hims & Hers $1.2 Billion Global Leap: Can Eucalyptus Cure its GLP-1 Ills? appeared first on 24/7 Wall St..







